Sun Pharma Faces Rs 1.11 Crore Tax Demand Over Disallowed Input Tax Credit

Sun Pharmaceutical Industries Ltd faces Rs 1.11 crore tax demand over disallowed input tax credit, as per a recent order from the Joint Commissioner, CGST and Central Excise.
29-04-2024

Sun Pharma - Specialty' Way Of Driving Growth Prospects: Motilal Oswal

Values Sun Pharma at 30 times 12 months forward earnings to arrive at a target price of Rs 1,870.
24-04-2024

Sun Pharma-FDA: Regulatory Concerns At Dadra facility Can Dent Sentiment, Say Analysts

Analysts say that the FDA action at the Dadra unit can push Sun Pharma's stock into a price-wise corrective phase.
18-04-2024
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation regarding Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
15-04-2024
Next Page
Close

Let's Open Free Demat Account